Intest Res.  2018 Jul;16(3):366-373. 10.5217/ir.2018.16.3.366.

What's app? Electronic health technology in inflammatory bowel disease

• Walsh A
• Travis S

• KMID: 2417648
• DOI: http://doi.org/10.5217/ir.2018.16.3.366

Abstract

Electronic health (eHealth) data collection is increasingly used in many chronic illnesses, to track pattern of disease. eHealth systems have the potential to revolutionize care. Inflammatory bowel disease (IBD) is a paradigm for such an approach: this is a chronic disease that usually affects young and technologically literate patient population, who are motivated to be involved in their own care. A range of eHealth technologies are available for IBD. This review considers the strengths and weaknesses of 7 platforms that focus on patient-provider interaction. These have been developed in Denmark, United States, the Netherlands, and the United Kingdom, demonstrating an international interest in this form of technology and interaction. Not only do these technologies aim to improve care but they also have the potential to collect large amounts of information. Information includes demographics and patient reported outcomes (symptoms, quality of life), quality of care (steroid use, among other metrics) and outcomes such as hospitalization. These data could inform quality improvement programmes to improve their focus. eHealth technology is also open to machine learning to analyze large data sets, through which personalized algorithms may be developed.

Keyword

Mobile applications; Electronic health records; Inflammatory bowel disease

MeSH Terms

Biomedical Technology*
Chronic Disease
Data Collection
Dataset
Demography
Denmark
Electronic Health Records
Great Britain
Hospitalization
Humans
Inflammatory Bowel Diseases*
Machine Learning
Mobile Applications
Netherlands
Quality Improvement
Telemedicine
United States

Reference

1. Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2018; 390:2769–2778. PMID: 29050646.

2. van Deen WK, Choi JM, Zand A, et al. Sa1203 The development of e-Health tools for the management of inflammatory bowel diseases. Gastroenterology. 2014; 146(5 Suppl 1):S-229.

3. Rasmussen LM, Phanareth K, Nolte H, Backer V. Internet-based monitoring of asthma: a long-term, randomized clinical study of 300 asthmatic subjects. J Allergy Clin Immunol. 2005; 115:1137–1142. PMID: 15940125.

4. Cox D, Ritterband L, Magee J, Clarke W, Gonder-Frederick L. Blood glucose awareness training delivered over the internet. Diabetes Care. 2008; 31:1527–1528. PMID: 18477813.

5. Weinstock RS, Teresi JA, Goland R, et al. Glycemic control and health disparities in older ethnically diverse underserved adults with diabetes: five-year results from the Informatics for Diabetes Education and Telemedicine (IDEATel) study. Diabetes Care. 2011; 34:274–279. PMID: 21270184.

6. Boyne JJ, Vrijhoef HJ, Wit Rd, Gorgels AP. Telemonitoring in patients with heart failure, the TEHAF study: study protocol of an ongoing prospective randomised trial. Int J Nurs Stud. 2011; 48:94–99. PMID: 20615505.

7. Boyne JJ, Van Asselt AD, Gorgels AP, et al. Cost-effectiveness analysis of telemonitoring versus usual care in patients with heart failure: the TEHAF-study. J Telemed Telecare. 2013; 19:242–248. PMID: 24163233.

8. Omboni S, Ferrari R. The role of telemedicine in hypertension management: focus on blood pressure telemonitoring. Curr Hypertens Rep. 2015; 17:535. PMID: 25790799.

9. Kelly JJ, Sweigard KW, Shields K, Schneider D. Safety, effectiveness, and efficiency: a web-based virtual anticoagulation clinic. Jt Comm J Qual Saf. 2003; 29:646–651. PMID: 14679867.

10. Basch E, Deal AM, Dueck AC, et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA. 2017; 318:197–198. PMID: 28586821.

11. Wootton R, Geissbuhler A, Jethwani K, et al. Comparative performance of seven long-running telemedicine networks delivering humanitarian services. J Telemed Telecare. 2012; 18:305–311. PMID: 22869822.

12. Sutherland D, Hayter M. Structured review: evaluating the effectiveness of nurse case managers in improving health outcomes in three major chronic diseases. J Clin Nurs. 2009; 18:2978–2992. PMID: 19747197.

13. Kim AH, Roberts C, Feagan BG, et al. Developing a standard set of patient-centred outcomes for inflammatory bowel diseasean international, cross-disciplinary consensus. J Crohns Colitis. 2018; 12:408–418. PMID: 29216349.

14. Coons SJ, Gwaltney CJ, Hays RD, et al. Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report. Value Health. 2009; 12:419–429. PMID: 19900250.

15. Taenzer P, Bultz BD, Carlson LE, et al. Impact of computerized quality of life screening on physician behaviour and patient satisfaction in lung cancer outpatients. Psychooncology. 2000; 9:203–213. PMID: 10871716.

16. Gutteling JJ, Busschbach JJ, de Man RA, Darlington AS. Logistic feasibility of health related quality of life measurement in clinical practice: results of a prospective study in a large population of chronic liver patients. Health Qual Life Outcomes. 2008; 6:97. PMID: 19000316.

17. Erharter A, Giesinger J, Kemmler G, et al. Implementation of computer-based quality-of-life monitoring in brain tumor outpatients in routine clinical practice. J Pain Symptom Manage. 2010; 39:219–229. PMID: 20152586.

18. Wright EP, Selby PJ, Crawford M, et al. Feasibility and compliance of automated measurement of quality of life in oncology practice. J Clin Oncol. 2003; 21:374–382. PMID: 12525532.

19. Con D, De Cruz P. Mobile phone apps for inflammatory bowel disease self-management: a systematic assessment of content and tools. JMIR Mhealth Uhealth. 2016; 4:e13. DOI: 10.2196/mhealth.4874. PMID: 26831935.

20. Kappelman MD, Palmer L, Boyle BM, Rubin DT. Quality of care in inflammatory bowel disease: a review and discussion. Inflamm Bowel Dis. 2010; 16:125–133. PMID: 19572335.

21. Reddy SI, Friedman S, Telford JJ, Strate L, Ookubo R, Banks PA. Are patients with inflammatory bowel disease receiving optimal care? Am J Gastroenterol. 2005; 100:1357–1361. PMID: 15929770.

22. Elkjaer M, Burisch J, Avnstrøm S, Lynge E, Munkholm P. Development of a web-based concept for patients with ulcerative colitis and 5-aminosalicylic acid treatment. Eur J Gastroenterol Hepatol. 2010; 22:695–704. PMID: 19543101.

23. Cross RK, Cheevers N, Rustgi A, Langenberg P, Finkelstein J. Randomized, controlled trial of home telemanagement in patients with ulcerative colitis (UC HAT). Inflamm Bowel Dis. 2012; 18:1018–1025. PMID: 21688350.

24. Cross RK, Cheevers N, Finkelstein J. Home telemanagement for patients with ulcerative colitis (UC HAT). Dig Dis Sci. 2009; 54:2463–2472. PMID: 19104937.

25. Atreja A, Khan S, Rogers JD, et al. Impact of the mobile HealthPROMISE platform on the quality of care and quality of life in patients with inflammatory bowel disease: study protocol of a pragmatic randomized controlled trial. JMIR Res Protoc. 2015; 4:e23. PMID: 25693610.

26. de Jong M, van der Meulen-de Jong A, Romberg-Camps M, et al. Development and feasibility study of a telemedicine tool for all patients with IBD: myIBDcoach. Inflamm Bowel Dis. 2017; 23:485–493. PMID: 28267047.

27. Van Deen WK, van der Meulen-de Jong AE, Parekh NK, et al. Development and validation of an inflammatory bowel diseases monitoring index for use with mobile health technologies. Clin Gastroenterol Hepatol. 2016; 14:1742–1750.e7. PMID: 26598228.

28. Hou J, Weatherly J, Sellin J, et al. P-132 Feasibility of screening for anemia using the Crohn's and colitis foundation anemia care pathway in IBD Qorus. Inflamm Bowel Dis. 2017; 23:S46–S47.

29. Hou J, Xu A, Weatherly J, et al. P-129 CCFA quality of care breakthrough series collaborative: improving the delivery of urgent care for patients with IBD. Inflamm Bowel Dis. 2017; 23:S45–S46.

30. Walsh A. TrueColours: real time data collection in patients with ulcerative colitis [Doctoral dissertation]. Oxford, UK: University of Oxford;2017.

31. Pedersen N, Elkjaer M, Duricova D, et al. eHealth: individualisation of infliximab treatment and disease course via a self-managed web-based solution in Crohn’s disease. Aliment Pharmacol Ther. 2012; 36:840–849. PMID: 22971016.

32. Pedersen N, Thielsen P, Martinsen L, et al. eHealth: individualization of mesalazine treatment through a self-managed web-based solution in mild-to-moderate ulcerative colitis. Inflamm Bowel Dis. 2014; 20:2276–2285. PMID: 25248002.

33. Cross RK, Jambaulikar G, Langenberg P, et al. TELEmedicine for patients with inflammatory bowel disease (TELE-IBD): design and implementation of randomized clinical trial. Contemp Clin Trials. 2015; 42:132–144. PMID: 25812483.

34. Atreja A, Khan S, Otobo E, et al. P554 Impact of real world home based remote monitoring on quality of care and quality of life in inflammatory bowel disease patients: one year results of pragmatic randomized trial. J Crohns Colitis. 2017; 11:S362–S363.

35. de Jong M, Van Der Meulen A, Romberg-Camps M, et al. Telemedicine enables a safe shift from examination room based care to personalized care for inflammatory bowel disease: a pragmatic randomized multicenter trial with myIBDcoach. Gastroenterology. 2017; 152(5 Suppl 1):S186.

36. Elkjaer M, Shuhaibar M, Burisch J, et al. E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided ‘Constant-Care’ approach. Gut. 2010; 59:1652–1661. PMID: 21071584.

37. D'Haens G, Sandborn WJ, Feagan BG, et al. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology. 2007; 132:763–786. PMID: 17258735.